Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Mineral and Electrolyte Metabolism|January 1, 1987
Glycosaminoglycans as inhibitors of stone formationJ D SallisThe Journal of Pharmacy and Pharmacology|October 1, 1995
Liposome and multiple emulsion formulations augment the anticalcifying efficacy of phosphocitrate in a cutaneous calcergy modelH Kamperman, J D SallisCalcified Tissue International|March 1, 1982
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formationG Williams, J D SallisBiochemical and Biophysical Research Communications|September 16, 1985
Phosphocitrate inhibition of 45Ca2+ uptake in rat aortic smooth muscle cells in primary cultureR Shankar, J D SallisThe Biochemical Journal|October 15, 1979
Structure--activity relationship of inhibitors of hydroxyapatite formationG Williams, J D SallisInvestigative Urology|January 1, 1979
On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stonesJ D Sallis, M F LumleyAnalytical Biochemistry|July 1, 1983
The synthesis and characterization of N-sulfo-2-amino tricarballylate: an analog of phosphocitrate and inhibitor of calcificationM R Brown, J D SallisAtherosclerosis|August 1, 1984
Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcificationR Shankar, S Crowden, J D SallisAtherosclerosis|October 1, 1986
Atherogenesis. Mitigation of monocyte adhesion to arterial endothelium in hyperlipidemic rats by phosphocitrate, a phosphorylated polycarboxylic acidR Shankar, N Tuyethong, J D SallisAtherosclerosis|May 1, 1987
A possible antiatherogenic role for phosphocitrate through modulation of low density lipoprotein uptake and degradation in aortic smooth muscle cellsL C Ward, R Shankar, J D SallisPageof 3